Prospective Study of Metastatic Lung Cancer Patients

Background: Worldwide cancer is becoming leading cause of death. Cancer incidence and mortality are rapidly growing worldwide. Among men prostate and lung cancer are the most frequently diagnosed cancers. Among males lung cancer is the leading cause of death in most countries. Materials and Methods: This was a prospective observational study done at Apollo Gleneagles Hospital, Kolkata in Department of Medical Oncology. Clinical and treatment details of all consecutive patients with metastatic lung cancer who underwent treatment at our center between August 2017 to July 2019 were collected and analyzed. A total of 54 patients were registered in the study. Results: Non-small cell lung cancer (NSCLC) patients comprised 50 and small cell lung cancer (SCLC) patients comprised 4 out of them. Median age was 56 years for NSCLC and 62 years for SCLC. Among NSCLC, adenocarcinoma was the commonest histological sub type. Males were 64 % and female 36 % of all NSCLC, while all SCLC patients were males. Conclusions: This study was conducted to know the demographic characteristics, histopathological and molecular characteristics, treatment pattern and outcome of metastatic lung cancer patients. Prevalence of EGFR mutation in non-small cell lung cancer was lower than expected and outcome of treatment was poor.